Geopolitics Alpha

Lyell Immunopharma (LYEL): filings, insider buys & geopolitical news

In the last 30 days, Geopolitics Alpha logged 1 item on Lyell Immunopharma: 0 news stories, 1 SEC filing and 0 fund or insider trade reports. The latest filing was logged 04 Nov 2026: 8-K - Lyell Immunopharma, Inc. (0001806952) (Filer).

Government contracts

No federal prime contract obligations are matched to Lyell Immunopharma in USAspending.gov for the last five years, and no Department of Defense contract announcements name it in the past year. See the largest government contractors.

LYEL share price, last 12 months

Close $13.50 on Jun 12, 2026, -19.0% since Oct 31, 2025 (range $11.97 to $38.60, daily closes).

What changed for Lyell Immunopharma (LYEL)

In the last 30 days, Geopolitics Alpha logged 1 item on Lyell Immunopharma: 0 news stories, 1 SEC filing and 0 fund or insider trade reports. The latest filing was logged 04 Nov 2026: 8-K - Lyell Immunopharma, Inc. (0001806952) (Filer).

Latest SEC filings

Latest fund & insider buys and sales

None on record yet.

Latest geopolitical & market news

None on record yet.

Congressional trades in LYEL

Trades in LYEL that members of Congress have publicly reported, newest filing first.

No congressional trades are stored for this view yet.

All congressional stock trades →

Geopolitical news for LYEL

Everything on LYEL, newest first

Frequently asked questions

Does Lyell Immunopharma have government contracts?

No federal prime contract obligations are matched to Lyell Immunopharma (LYEL) in USAspending.gov for the last five years. Subcontracts are not included.

Where does the contract data come from?

USAspending.gov (the official source of U.S. federal spending data) and the Department of Defense's daily contract announcements. Both are public domain and refreshed daily here.

What geopolitical news affects LYEL?

This page lists every Geopolitics Alpha note that names LYEL as exposed to an event, with the reason it is exposed.

Has Congress traded LYEL?

The table above lists trades in LYEL that members of Congress have publicly reported, with a link to each official filing.

Is this investment advice?

No. We show news, exposure and past price moves. Nothing here is a recommendation.